| | | | | | | |
 | GILEAD SCIENCES, INC. | 4.92% | 3.06% | -9.03% | -7.89% | 5.07% | 78 912 |
| VERTEX PHARMACEUTICALS | 3.57% | 2.25% | 38.90% | 59.72% | 68.41% | 75 532 |
| REGENERON PHARMACEUTICALS, INC. | 2.11% | 2.46% | 1.66% | 2.13% | 119.03% | 67 214 |
 | WUXI APPTEC CO., LTD. | -0.28% | 0.77% | -20.33% | -31.91% | 125.92% | 40 830 |
| BIONTECH SE | 1.41% | -12.43% | -36.93% | -52.61% | --.--% | 38 968 |
 | GENMAB A/S | 2.12% | 3.09% | 2.36% | -8.03% | 100.07% | 23 726 |
 | ARGENX SE | 2.51% | 1.64% | 19.03% | 43.74% | 209.91% | 20 669 |
| BEIGENE, LTD. | 1.73% | -0.26% | -27.17% | -29.67% | 39.75% | 20 070 |
| NEUROCRINE BIOSCIENCES, INC. | 1.61% | 1.53% | 26.02% | 19.02% | 13.12% | 10 102 |
| SAREPTA THERAPEUTICS, INC. | -0.17% | 2.81% | 20.84% | 42.19% | -10.78% | 9 545 |
| KARUNA THERAPEUTICS, INC. | -1.60% | 97.65% | 108.39% | 160.33% | 1,151.65% | 9 277 |
| LEGEND BIOTECH CORPORATION | -0.64% | -5.76% | 0.15% | 19.75% | --.--% | 7 652 |
| EXELIXIS, INC. | -0.10% | -9.48% | 6.46% | 5.25% | -2.41% | 6 269 |
| ASCENDIS PHARMA A/S | -3.49% | 16.14% | -20.92% | -8.47% | -7.34% | 6 152 |
| HALOZYME THERAPEUTICS, INC. | 0.19% | -4.41% | 7.49% | 4.72% | 172.68% | 5 944 |
| | | | | | | |
| | Promedio | 0.93% | 6.60% | 7.79% | 14.55% | 152.70% | |
| | Media ponderada por Capi. | 2.27% | 2.72% | 3.32% | 7.22% | 101.27% | |
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Reporte
